entrinsic bioscience Secures $49 Million in Financing

Aitechpark09 Jun, 2021Technology

? Groundbreaking Platform Poised to Disrupt Multiple Consumer Health and Therapeutic Markets ? entrinsic bioscience, Working with Aon, Leverages its IP Portfolio to Secure Insurancebacked Financing from Jefferies Funding LLC with Limited Equity Dilution entrinsic bioscience (EBS)announced that it has secured $49 million in non-dilutive growth capital from Jefferies Group LLC?s subsidiary, Jefferies Funding LLC (Jefferies). The event follows Series A and B raises, including multiple rounds of investment from Johnson & Johnson INNOVATION | JJDC. Aon Plc?s Intellectual Property Solutions also played an important role in helping to secure key Collateral Protection Insurance to support the financing.